65 related articles for article (PubMed ID: 38513802)
21. MicroRNAs and their vital role in apoptosis in hepatocellular carcinoma: miRNA-based diagnostic and treatment methods.
Hajizadeh M; Hajizadeh F; Ghaffarei S; Amin Doustvandi M; Hajizadeh K; Yaghoubi SM; Mohammadnejad F; Khiabani NA; Mousavi P; Baradaran B
Gene; 2023 Dec; 888():147803. PubMed ID: 37716587
[TBL] [Abstract][Full Text] [Related]
22. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
Zhou Y; Liu F; Ma C; Cheng Q
J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748
[TBL] [Abstract][Full Text] [Related]
23. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
Front Immunol; 2022; 13():985815. PubMed ID: 36300115
[TBL] [Abstract][Full Text] [Related]
24. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
George J; Patel T
Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
[TBL] [Abstract][Full Text] [Related]
25. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
26. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S
Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455
[TBL] [Abstract][Full Text] [Related]
27. An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches.
Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Papanikolopoulos K; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Matthaios D; Karamouzis MV
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108330
[TBL] [Abstract][Full Text] [Related]
28. Prospects of Noncoding RNAs in Hepatocellular Carcinoma.
Zhou H; Xu Q; Ni C; Ye S; Xu X; Hu X; Jiang J; Hong Y; Huang D; Yang L
Biomed Res Int; 2018; 2018():6579436. PubMed ID: 30148169
[TBL] [Abstract][Full Text] [Related]
29. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review.
Oura K; Morishita A; Masaki T
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171811
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNAs in hepatocellular carcinoma: Ordering of the complicated lncRNA regulatory network and novel strategies for HCC clinical diagnosis and treatment.
Li C; Yang J; Liu C; Wang X; Zhang L
Pharmacol Res; 2020 Aug; 158():104848. PubMed ID: 32389858
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets.
Hashemi M; Mirzaei S; Zandieh MA; Rezaei S; Amirabbas Kakavand ; Dehghanpour A; Esmaeili N; Ghahremanzade A; Saebfar H; Heidari H; Salimimoghadam S; Taheriazam A; Entezari M; Ahn KS
Prog Biophys Mol Biol; 2023 Jan; 177():207-228. PubMed ID: 36584761
[TBL] [Abstract][Full Text] [Related]
34. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
35. Non‑coding RNAs: Role of miRNAs and lncRNAs in the regulation of autophagy in hepatocellular carcinoma (Review).
Wu J; Zhu Y; Cong Q; Xu Q
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083063
[TBL] [Abstract][Full Text] [Related]
36. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D
World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871
[TBL] [Abstract][Full Text] [Related]
37. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
[TBL] [Abstract][Full Text] [Related]
38. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
39. [microRNA: new diagnostic and therapeutic tools in liver disease?].
Gougelet A; Colnot S
Med Sci (Paris); 2013 Oct; 29(10):861-7. PubMed ID: 24148124
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.
Greene CM; Varley RB; Lawless MW
World J Gastroenterol; 2013 Aug; 19(32):5212-26. PubMed ID: 23983424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
